MUTANTES DE FGF21 Y USOS DEL MISMO

La invención proporciona moléculas de ácido nucleico que codifican polipéptidos mutantes FGF21, polipéptidos mutantes FGF21, composiciones farmacéuticas que comprenden polipéptidos mutantes FGF21, y métodos para tratar trastornos metabólicos usando dichos ácidos nucleicos, polipéptidos, o composicio...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LI, Yue-Sheng, XU, Jing, SUN, Jeonghoon, BELOUSKI, Edward John, MICHAELS, Mark Leo, HAMBURGER, Agnes Eva, ELLISON, Murielle, HECHT, Randy Ira
Format:	Patent
Sprache:	spa
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	LI, Yue-Sheng XU, Jing SUN, Jeonghoon BELOUSKI, Edward John MICHAELS, Mark Leo HAMBURGER, Agnes Eva ELLISON, Murielle HECHT, Randy Ira
description	La invención proporciona moléculas de ácido nucleico que codifican polipéptidos mutantes FGF21, polipéptidos mutantes FGF21, composiciones farmacéuticas que comprenden polipéptidos mutantes FGF21, y métodos para tratar trastornos metabólicos usando dichos ácidos nucleicos, polipéptidos, o composiciones farmacéuticas. The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides, pharmaceutical compositions comprising FGF21 mutant polypeptides, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_UY38740A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>UY38740A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_UY38740A3</originalsourceid><addsrcrecordid>eNrjZFDyDQ1x9AtxDVZwcVVwc3czMlSIVAgN9gfxfRR8PYN9_XkYWNMSc4pTeaE0N4Osm2uIs4duakF-fGpxQWJyal5qSXxopLGFuYmBozEheQAOqiCU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MUTANTES DE FGF21 Y USOS DEL MISMO</title><source>esp@cenet</source><creator>LI, Yue-Sheng ; XU, Jing ; SUN, Jeonghoon ; BELOUSKI, Edward John ; MICHAELS, Mark Leo ; HAMBURGER, Agnes Eva ; ELLISON, Murielle ; HECHT, Randy Ira</creator><creatorcontrib>LI, Yue-Sheng ; XU, Jing ; SUN, Jeonghoon ; BELOUSKI, Edward John ; MICHAELS, Mark Leo ; HAMBURGER, Agnes Eva ; ELLISON, Murielle ; HECHT, Randy Ira</creatorcontrib><description>La invención proporciona moléculas de ácido nucleico que codifican polipéptidos mutantes FGF21, polipéptidos mutantes FGF21, composiciones farmacéuticas que comprenden polipéptidos mutantes FGF21, y métodos para tratar trastornos metabólicos usando dichos ácidos nucleicos, polipéptidos, o composiciones farmacéuticas. The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides, pharmaceutical compositions comprising FGF21 mutant polypeptides, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions.</description><language>spa</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201231&DB=EPODOC&CC=UY&NR=38740A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201231&DB=EPODOC&CC=UY&NR=38740A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LI, Yue-Sheng</creatorcontrib><creatorcontrib>XU, Jing</creatorcontrib><creatorcontrib>SUN, Jeonghoon</creatorcontrib><creatorcontrib>BELOUSKI, Edward John</creatorcontrib><creatorcontrib>MICHAELS, Mark Leo</creatorcontrib><creatorcontrib>HAMBURGER, Agnes Eva</creatorcontrib><creatorcontrib>ELLISON, Murielle</creatorcontrib><creatorcontrib>HECHT, Randy Ira</creatorcontrib><title>MUTANTES DE FGF21 Y USOS DEL MISMO</title><description>La invención proporciona moléculas de ácido nucleico que codifican polipéptidos mutantes FGF21, polipéptidos mutantes FGF21, composiciones farmacéuticas que comprenden polipéptidos mutantes FGF21, y métodos para tratar trastornos metabólicos usando dichos ácidos nucleicos, polipéptidos, o composiciones farmacéuticas. The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides, pharmaceutical compositions comprising FGF21 mutant polypeptides, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFDyDQ1x9AtxDVZwcVVwc3czMlSIVAgN9gfxfRR8PYN9_XkYWNMSc4pTeaE0N4Osm2uIs4duakF-fGpxQWJyal5qSXxopLGFuYmBozEheQAOqiCU</recordid><startdate>20201231</startdate><enddate>20201231</enddate><creator>LI, Yue-Sheng</creator><creator>XU, Jing</creator><creator>SUN, Jeonghoon</creator><creator>BELOUSKI, Edward John</creator><creator>MICHAELS, Mark Leo</creator><creator>HAMBURGER, Agnes Eva</creator><creator>ELLISON, Murielle</creator><creator>HECHT, Randy Ira</creator><scope>EVB</scope></search><sort><creationdate>20201231</creationdate><title>MUTANTES DE FGF21 Y USOS DEL MISMO</title><author>LI, Yue-Sheng ; XU, Jing ; SUN, Jeonghoon ; BELOUSKI, Edward John ; MICHAELS, Mark Leo ; HAMBURGER, Agnes Eva ; ELLISON, Murielle ; HECHT, Randy Ira</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_UY38740A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2020</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>LI, Yue-Sheng</creatorcontrib><creatorcontrib>XU, Jing</creatorcontrib><creatorcontrib>SUN, Jeonghoon</creatorcontrib><creatorcontrib>BELOUSKI, Edward John</creatorcontrib><creatorcontrib>MICHAELS, Mark Leo</creatorcontrib><creatorcontrib>HAMBURGER, Agnes Eva</creatorcontrib><creatorcontrib>ELLISON, Murielle</creatorcontrib><creatorcontrib>HECHT, Randy Ira</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LI, Yue-Sheng</au><au>XU, Jing</au><au>SUN, Jeonghoon</au><au>BELOUSKI, Edward John</au><au>MICHAELS, Mark Leo</au><au>HAMBURGER, Agnes Eva</au><au>ELLISON, Murielle</au><au>HECHT, Randy Ira</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MUTANTES DE FGF21 Y USOS DEL MISMO</title><date>2020-12-31</date><risdate>2020</risdate><abstract>La invención proporciona moléculas de ácido nucleico que codifican polipéptidos mutantes FGF21, polipéptidos mutantes FGF21, composiciones farmacéuticas que comprenden polipéptidos mutantes FGF21, y métodos para tratar trastornos metabólicos usando dichos ácidos nucleicos, polipéptidos, o composiciones farmacéuticas. The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides, pharmaceutical compositions comprising FGF21 mutant polypeptides, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	spa
recordid	cdi_epo_espacenet_UY38740A
source	esp@cenet
subjects	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
title	MUTANTES DE FGF21 Y USOS DEL MISMO
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T00%3A01%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LI,%20Yue-Sheng&rft.date=2020-12-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUY38740A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true